ABBV

AbbVie Inc.

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

AbbVie Inc. (ABBV) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 C+ (2.6) C (2.3) A- (3.9) A- (3.9) C (2.3) B- (3.0)
2026-11-12 C+ (2.5) C (2.3) A- (3.9) A- (3.9) B+ (3.5) B (3.2)
2026-11-09 C+ (2.5) C (2.3) A- (3.9) A- (3.9) B (3.5) B (3.2)
2026-11-07 C+ (2.5) C (2.2) A (4.4) B+ (3.7) B (3.4) B (3.3)
2026-11-05 C+ (2.5) C (2.2) A (4.4) B+ (3.7) B (3.5) B (3.2)
Page 1 of 4

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe